Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Hypergammaglobulinemia sustains the development of regulatory responses during chronic Leishmania donovani infection in mice.

Authors: Silva-Barrios, Sasha  Stäger, Simona 
Citation: Silva-Barrios S and Stäger S, Eur J Immunol. 2019 Jul;49(7):1082-1091. doi: 10.1002/eji.201847917. Epub 2019 May 23.
Pubmed: (View Article at PubMed) PMID:31001826
DOI: Full-text: DOI:10.1002/eji.201847917

Visceral leishmaniasis, a chronic, potentially fatal disease, is characterized by high production of low-affinity antibodies. In humans, hypergammaglobulinemia is prediction of disease progression. Nevertheless, the contribution of hypermutated and/or class-switched immunoglobulins to disease pathogenesis has never been studied. Using Aicda-/- mice and the experimental model of Leishmania donovani infection, we demonstrate that the absence of hypermutated and/or class-switched antibodies was associated with increased resistance to disease, stronger protective Th1 responses, and a lower frequency of regulatory IFNγ+ IL-10+ CD4 T cells. Interestingly, stronger Th1 responses and the absence of IFNγ+ IL-10+ CD4 T cells during chronic infection in infected Aicda-/- mice were not caused by a T-cell intrinsic effect of AID, but by changes in the cytokine environment during chronic disease. Indeed TNF, IL-10 and IFN-ß expressions were only upregulated in the presence of hypermutated, class-switched antibodies and hypergammaglobulinemia at later stages of infection. Taken together, our results suggest that hypergammaglobulinemia sustains inhibitory responses during chronic visceral leishmaniasis.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 32716386
Created: 2020-06-26
Species: All species
Last Modified: 2020-06-26
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.